{
  "DOI": "10.1038/ejhg.2016.92",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2016.92",
  "alternative-id": [
    "BFejhg201692"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Capoluongo",
      "given": "Ettore",
      "sequence": "first"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ],
    "date-time": "2016-08-12T08:50:59Z",
    "timestamp": 1470991859000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:17:56Z",
    "timestamp": 1684430276000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        5,
        19
      ]
    ],
    "date-time": "2023-05-19T04:54:58Z",
    "timestamp": 1684472098449
  },
  "is-referenced-by-count": 10,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "S1",
  "issued": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "S1",
    "published-print": {
      "date-parts": [
        [
          2016,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            8,
            12
          ]
        ],
        "date-time": "2016-08-12T00:00:00Z",
        "timestamp": 1470960000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg201692.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201692",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201692.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "S1-S2",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        8,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/ng1294-399",
      "author": "LS Friedman",
      "doi-asserted-by": "publisher",
      "first-page": "399",
      "journal-title": "Nat Genet",
      "key": "BFejhg201692_CR1",
      "unstructured": "Friedman LS, Ostermeyer EA, Szabo CI et al: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994; 8: 399–404.",
      "volume": "8",
      "year": "1994"
    },
    {
      "DOI": "10.1126/science.7545954",
      "author": "Y Miki",
      "doi-asserted-by": "publisher",
      "first-page": "66",
      "journal-title": "Science",
      "key": "BFejhg201692_CR2",
      "unstructured": "Miki Y, Swensen J, Shattuck-Eidens D et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71.",
      "volume": "266",
      "year": "1994"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg201692_CR3",
      "unstructured": "Antoniou A, Pharoah PD, Narod S et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117–1130.",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1329",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201692_CR4",
      "unstructured": "Chen S, Parmigiani G : Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007; 25: 1329–1333.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s12687-011-0042-4",
      "author": "D Gadzicki",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "journal-title": "J Community Genet",
      "key": "BFejhg201692_CR5",
      "unstructured": "Gadzicki D, Evans DG, Harris H et al: Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet 2011; 2: 53–69.",
      "volume": "2",
      "year": "2011"
    },
    {
      "key": "BFejhg201692_CR6",
      "unstructured": "NICE Clinical Guidelines: NICE Clinical Guidance 164: Familial Breast Cancer. NICE Clinical Guidelines 2013, Available at https://www.nice.org.uk/guidance/cg164 ."
    },
    {
      "DOI": "10.1016/S0140-6736(10)60893-8",
      "author": "MW Audeh",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "journal-title": "Lancet",
      "key": "BFejhg201692_CR7",
      "unstructured": "Audeh MW, Carmichael J, Penson RT et al: Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 2010; 376: 245–251.",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S1470-2045(14)70228-1",
      "author": "J Ledermann",
      "doi-asserted-by": "publisher",
      "first-page": "852",
      "journal-title": "Lancet Oncol",
      "key": "BFejhg201692_CR8",
      "unstructured": "Ledermann J, Harter P, Gourley C et al: Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol 2014; 15: 852–861.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(10)60892-6",
      "author": "A Tutt",
      "doi-asserted-by": "publisher",
      "first-page": "235",
      "journal-title": "Lancet",
      "key": "BFejhg201692_CR9",
      "unstructured": "Tutt A, Robson M, Garber JE et al: Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 2010; 376: 235–244.",
      "volume": "376",
      "year": "2010"
    },
    {
      "author": "N Collins",
      "first-page": "1673",
      "journal-title": "Oncogene",
      "key": "BFejhg201692_CR10",
      "unstructured": "Collins N, McManus R, Wooster R et al: Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995; 10: 1673–1675.",
      "volume": "10",
      "year": "1995"
    },
    {
      "DOI": "10.1038/sj.onc.1209874",
      "author": "K Gudmundsdottir",
      "doi-asserted-by": "publisher",
      "first-page": "5864",
      "journal-title": "Oncogene",
      "key": "BFejhg201692_CR11",
      "unstructured": "Gudmundsdottir K, Ashworth A : The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 2006; 25: 5864–5874.",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.4161/cc.7.18.6679",
      "author": "Z Mao",
      "doi-asserted-by": "publisher",
      "first-page": "2902",
      "journal-title": "Cell Cycle",
      "key": "BFejhg201692_CR12",
      "unstructured": "Mao Z, Bozzella M, Seluanov A, Gorbunova V : DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle 2008; 7: 2902–2906.",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1242/jcs.114.20.3591",
      "author": "AR Venkitaraman",
      "doi-asserted-by": "crossref",
      "first-page": "3591",
      "journal-title": "J Cell Sci",
      "key": "BFejhg201692_CR13",
      "unstructured": "Venkitaraman AR : Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci 2001; 114: 3591–3598.",
      "volume": "114",
      "year": "2001"
    },
    {
      "DOI": "10.1001/jama.2014.5985",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1347",
      "journal-title": "JAMA",
      "key": "BFejhg201692_CR14",
      "unstructured": "Rebbeck TR, Mitra N, Wan F et al: Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 2015; 313: 1347–1361.",
      "volume": "313",
      "year": "2015"
    },
    {
      "DOI": "10.1038/jid.2013.248",
      "author": "A Grada",
      "doi-asserted-by": "publisher",
      "first-page": "e11",
      "journal-title": "J Invest Dermatol",
      "key": "BFejhg201692_CR15",
      "unstructured": "Grada A, Weinbrecht K : Next-generation sequencing: methodology and application. J Invest Dermatol 2013; 133: e11.",
      "volume": "133",
      "year": "2013"
    },
    {
      "DOI": "10.1586/erm.13.1",
      "author": "SF Idris",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "journal-title": "Expert Rev Mol Diagn",
      "key": "BFejhg201692_CR16",
      "unstructured": "Idris SF, Ahmad SS, Scott MA, Vassiliou GS, Hadfield J : The role of high-throughput technologies in clinical cancer genomics. Expert Rev Mol Diagn 2013; 13: 167–181.",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nbt.2198",
      "author": "NJ Loman",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg201692_CR17",
      "unstructured": "Loman NJ, Misra RV, Dallman TJ et al: Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 2012; 30: 434–439.",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1146/annurev.genom.9.081307.164359",
      "author": "ER Mardis",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Annu Rev Genomics Hum Genet",
      "key": "BFejhg201692_CR18",
      "unstructured": "Mardis ER : Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008; 9: 387–402.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.1007983107",
      "author": "T Walsh",
      "doi-asserted-by": "publisher",
      "first-page": "12629",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg201692_CR19",
      "unstructured": "Walsh T, Lee MK, Casadei S et al: Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 2010; 107: 12629–12633.",
      "volume": "107",
      "year": "2010"
    },
    {
      "DOI": "10.18632/oncotarget.503",
      "author": "H Do",
      "doi-asserted-by": "publisher",
      "first-page": "546",
      "journal-title": "Oncotarget",
      "key": "BFejhg201692_CR20",
      "unstructured": "Do H, Dobrovic A : Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase. Oncotarget 2012; 3: 546–558.",
      "volume": "3",
      "year": "2012"
    },
    {
      "DOI": "10.1373/clinchem.2012.202390",
      "author": "H Do",
      "doi-asserted-by": "publisher",
      "first-page": "1376",
      "journal-title": "Clin Chem",
      "key": "BFejhg201692_CR21",
      "unstructured": "Do H, Wong SQ, Li J, Dobrovic A : Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. Clin Chem 2013; 59: 1376–1383.",
      "volume": "59",
      "year": "2013"
    },
    {
      "DOI": "10.1186/1755-8794-7-23",
      "author": "SQ Wong",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "BMC Med Genomics",
      "key": "BFejhg201692_CR22",
      "unstructured": "Wong SQ, Li J, Tan AY et al: Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genomics 2014; 7: 23.",
      "volume": "7",
      "year": "2014"
    },
    {
      "DOI": "10.1586/14737159.2015.1081059",
      "author": "A Minucci",
      "doi-asserted-by": "publisher",
      "first-page": "1383",
      "journal-title": "Expert Rev Mol Diagn",
      "key": "BFejhg201692_CR23",
      "unstructured": "Minucci A, Scambia G, Santonocito C et al: Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review. Expert Rev Mol Diagn 2015; 15: 1383–1403.",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1093/annonc/mdu338.7",
      "author": "A George",
      "doi-asserted-by": "publisher",
      "first-page": "iv307",
      "issue": "Suppl 4",
      "journal-title": "Ann Oncol",
      "key": "BFejhg201692_CR24",
      "unstructured": "George A, Smith F, Cloke V et al: Implementation of routine BRCA gene testing of ovarian cancer (OC) patients at Royal Marsden Hospital. Ann Oncol 2014; 25 (Suppl 4): iv307.",
      "volume": "25",
      "year": "2014"
    },
    {
      "author": "AS Sie",
      "first-page": "143",
      "journal-title": "Fam Cancer",
      "key": "BFejhg201692_CR25",
      "unstructured": "Sie AS, van Zelst-Stams WA, Spruijt L et al: More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling. Fam Cancer 2014; 13: 143–151.",
      "volume": "13",
      "year": "2014"
    }
  ],
  "reference-count": 25,
  "references-count": 25,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg201692"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "BRCA to the future: towards best testing practice in the era of personalised healthcare"
  ],
  "type": "journal-article",
  "volume": "24"
}